Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits

Vascular Medicine

Volumn 10, Issue 4, 2005, Pages 285-291

  Dulak, Jozef ^a,b   Schwarzacher, Severin P ^a   Zwick, Ralf H ^a   Alber, Hannes ^a   Millonig, Gunda ^c   Weiss, Caecilia ^a   Hügel, Heike ^a   Frick, Matthias ^a   Jozkowicz, Alicja ^b   Pachinger, Otmar ^a   Weidinger, Franz ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Atherosclerosis; Gene therapy; Vascular endothelial growth factor

Indexed keywords

ARGININE; BETA GALACTOSIDASE; CHOLESTEROL; NITRIC OXIDE; PLASMID DNA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BALLOON; BLOOD VESSEL; CHOLESTEROL DIET; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG INFUSION; GENE THERAPY; GENE TRANSFER; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; IMMUNOCYTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; STATISTICAL SIGNIFICANCE;

ANGIOPLASTY, BALLOON; ANIMALS; ARGININE; DIETARY FATS; DISEASE MODELS, ANIMAL; HUMANS; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; MALE; PLASMIDS; RABBITS; TRANSFECTION; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 31344458492     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x05vm630oa     Document Type: Article

References (42)

1. Takeshita S, Tsurumi Y, Couffinahl T et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996; 75: 487-501.
2. Tsurumi Y, Takeshita S, Chen D et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94: 3281-90.
3. 165 gene transfer. Circulation 1996; 94: 3291-302.
4. Van Belle E, Tio FO, Chen D et al. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 1997; 29: 1371-79.
5. Laitinen M, Zachary I, Breier G et al. VEGF gene transfer reduces intinial thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 1997; 8: 1737-44.
6. Ziche M, Morbidelli L, Choudhuri R et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-34.
7. Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-78.
8. Schwarzacher S, Lim TT, Wang BY et al. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997; 95: 1863-69.
9. Hedman M, Hartikainen J, Syvanne M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-83 (epub 12 May 2003).
10. Rajagopalan S, Mohler ER 3rd, Lederman RJ et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003; 108: 1933-38.
11. Dulak J, Józkowicz A, Ratajska A et al. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells. Vasc Med 2000; 5: 33-40.
12. Dulak J, Partyka L, Jozkowicz A et al. Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischemic limb muscles. Eur Surg 2002; 34: 105-10.
13. Weidinger FF, McLenachan JM, Cybulsky MI et al. Persistent dysfunction of regenerated endothelium after balloon angioplasty. of rabbit iliac artery. Circulation 1990; 81: 1667-79.
14. Laitinen M, Hartikainen J, Hiltunen MO et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000; 11: 263-70.
15. Magovern CJ, Mack CA, Zhang J et al. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther 1997; 8: 215-27.
16. Hiltunen MO, Laitinen M, Turunen MP et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2000; 102: 2262-68.
17. Inoue M, Itoh H, Ueda M et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-16.
18. Ramos MA, Kuzuya M, Esaki T et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998; 18: 1188-96.
19. Inoue M, Itoh H, Tanaka T et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 2001; 21: 560-66.
20. Celletti FL, Waugh JM, Amabile PG et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7: 425-29.
21. Celletti FL, Hilfiker PR, Ghafouri P, Dake MD. Effect of human recombinant vascular endothelial growth factor 165 on progression of atherosclerotic plaque. J Am Coll Cardiol 2001; 37: 2126-30.
22. Zhao Q, Egashira K, Inoue S et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002; 105: 1110-15.
23. Yonemitsu Y, Kaneda Y, Morishita R. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases. Lab Invest 1996; 75: 313-23.
24. Zhao Q, Egashira K, Hiasa K-I et al. Essential role of vascular endothelial growth factor and flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol 2004; 24: 2284-89.
25. Ohtani K, Egashira K, Hiasa K-I et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 2004; 110: 2444-52.
26. Khurana R, Shafi S, Martin J, Zachary I. Vascular endothelial growth factor gene transfer inhibits neointimal macrophage accumulation in hypercholsterolemic rabbits. Arterioscler Thrumb Vasc Biol 2004; 24: 1074-80.
27. Khurana R, Zhuang Z, Bhardwaj S et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 2004; 110: 2436-43.
28. Hutter R, Carrick FE, Valvidiezo C et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004; 110: 2430-35.
29. Dulak J, Jozkowicz A, Dichtl W et al. Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide production. Atherosclerosis 2001; 159: 325-32.
30. Wysocki SJ, Zheng MH, Smith A, Norman PE. Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig. Eur J Vasc Endovasc Surg 1998; 15: 225-30.
31. Hausner EA, Orsini JA, Foster LL et al. Vascular endothelial growth factor in porcine coronary arteries following balloon angioplasty. J Invest Surg 1999; 12: 15-23.
32. Janero DR, Ewing JF. Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential. Free Radic Biol Med 2000; 29: 1199-221.
33. Brandes RP, Behra A, Lebherz C et al. N(G)-nitro-L-arginine-and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis 1997; 135: 49-55.
34. Niebauer J, Schwarzacher S, Hayase M et al. Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation 1999; 100: 1830-35.
35. Suzuki T, Hayase M, Hibi K et al. Effect of local delivery of L-arginine on in-stent restenosis in humans. Am J Cardiol 2002; 89: 363-67.
36. Miyazaki H, Matsuoka H, Cooke JP et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99: 1141-64.
37. Jang JJ, Ho HK, Kwan HH, Fajardo LF, Cooke JP. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation 2000; 102: 1414-19.
38. Lundman P, Eriksson MJ, Stuhlinger M et al. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001; 38: 111-16.
39. Stuhlinger MC, Tsao PS, Her JH et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001; 104: 2569-75.
40. Henry TD, Annex BH, McKendall GR et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 2003; 107: 1359-65.
41. Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther 2003; 10: 285-91.
42. Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701.